Scholarly Index
Akira Andoh
Shiga University of Medical Science; 21,148 total citations; 561 total publications; best world rank #73
Shiga University of Medical Science
21,148Total citations
561Total publications
74H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Inflammatory Bowel Disease | Lifetime | 92 | JP 4 | 99.37 |
| Gut microbiota and health | Lifetime | 176 | JP 7 | 99.30 |
| Helicobacter pylori-related gastroenterology studies | Lifetime | 262 | JP 29 | 98.84 |
| Microscopic Colitis | Lifetime | 159 | JP 4 | 98.98 |
| Clostridium difficile and Clostridium perfringens research | Lifetime | 217 | JP 4 | 98.17 |
| Pancreatitis Pathology and Treatment | Lifetime | 483 | JP 61 | 97.89 |
| IL-33, ST2, and ILC Pathways | Lifetime | 225 | JP 16 | 97.73 |
| Immunodeficiency and Autoimmune Disorders | Lifetime | 800 | JP 21 | 96.98 |
| Complement system in diseases | Lifetime | 423 | JP 19 | 96.40 |
| Galectins and Cancer Biology | Lifetime | 726 | JP 81 | 94.12 |
| Whipple's Disease and Interleukins | Lifetime | 73 | JP 4 | 92.39 |
| Autoimmune and Inflammatory Disorders | Lifetime | 521 | JP 25 | 93.20 |
| IL-33, ST2, and ILC Pathways | 2021-2025 | 183 | JP 16 | 90.56 |
| Inflammatory Bowel Disease | 2021-2025 | 668 | JP 38 | 92.85 |
| Clostridium difficile and Clostridium perfringens research | 2021-2025 | 751 | JP 16 | 81.19 |